These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24229665)

  • 1. Change of glutamic acid decarboxylase antibody and protein tyrosine phosphatase antibody in Chinese patients with acute-onset type 1 diabetes mellitus.
    Chao C; Huang G; Li X; Yang L; Lin J; Jin P; Luo SM; Zhang YY; Pan LL; Zhou ZG
    Chin Med J (Engl); 2013 Nov; 126(21):4006-12. PubMed ID: 24229665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
    Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
    Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome.
    Morgenthaler NG; Seissler J; Achenbach P; Glawe D; Payton M; Meinck HM; Christie MR; Scherbaum WA
    Autoimmunity; 1997; 25(4):203-11. PubMed ID: 9344328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
    J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
    Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
    Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
    Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives.
    Wang JP; Zhou ZG; Lin J; Huang G; Zhang C; Yang L; Yuan Y; Zhou HF; Zhou M; Hou C; Zhou WD; Peng H; Hagopian WA
    Tissue Antigens; 2007 Nov; 70(5):369-75. PubMed ID: 17919266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
    Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
    J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
    Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
    Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
    Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) participants.
    Sosenko JM; Skyler JS; Palmer JP; Krischer JP; Cuthbertson D; Yu L; Schatz DA; Orban T; Eisenbarth G;
    Diabetes Care; 2011 Nov; 34(11):2435-7. PubMed ID: 21911777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental factors related to the induction of beta-cell autoantibodies in 1-yr-old healthy children.
    Wahlberg J; Fredriksson J; Nikolic E; Vaarala O; Ludvigsson J;
    Pediatr Diabetes; 2005 Dec; 6(4):199-205. PubMed ID: 16390388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
    Seissler J; Atik Y; Klinghammer A; Scherbaum WA
    Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic value of protein tyrosine phosphatase-2beta antibody (IA-2betaA) in type 1 diabetes].
    Li H; Huang G; Zhang S; Wang X; Jin HL; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):939-42. PubMed ID: 18756962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.
    Decochez K; Tits J; Coolens JL; Van Gaal L; Krzentowski G; Winnock F; Anckaert E; Weets I; Pipeleers DG; Gorus FK
    Diabetes Care; 2000 Jun; 23(6):838-44. PubMed ID: 10841006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes.
    Genovese S; Bazzigaluppi E; Gonçalves D; Ciucci A; Cavallo MG; Purrello F; Anello M; Rotella CM; Bardini G; Vaccaro O; Riccardi G; Travaglini P; Morenghi E; Bosi E; Pozzilli P
    Eur J Endocrinol; 2006 Mar; 154(3):441-7. PubMed ID: 16498058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
    Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
    Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.
    Savola K; Bonifacio E; Sabbah E; Kulmala P; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Meriläinen J; Akerblom HK; Knip M
    Diabetologia; 1998 Apr; 41(4):424-9. PubMed ID: 9562346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies against IA-2, GAD, and topoisomerase II in type 1 diabetic patients.
    Chang YH; Shiau MY; Tsai ST; Lan MS
    Biochem Biophys Res Commun; 2004 Jul; 320(3):802-9. PubMed ID: 15240119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.